2026-01-07 - Analysis Report
Okay, here's a comprehensive analysis of Salesforce Inc. (CRM) based on the provided data:

**0) Report in English: Simple Numbers & Analysis**

**1) Return Rate vs. S&P 500 (VOO)**

*   **Ticker:** CRM
*   **Company Name:** Salesforce Inc. - *A cloud-based software company providing customer relationship management (CRM) services.*
*   **CRM Cumulative Return:** -10.62%
*   **VOO Cumulative Return:** 91.00%
*   **Divergence:** -101.6 (Range: Max 46.2, Min -111.1, Relative Divergence: 6.0)

**Analysis:** CRM has significantly underperformed the S&P 500 (VOO) over the specified period. The large negative divergence indicates a substantial difference in returns, with CRM lagging far behind the overall market. The relative divergence of 6.0 suggests that the current divergence is near its worst historical level within the examined period.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha    | Beta  | Cap(B)  |
|------------|---------|---------|----------|-------|---------|
| 2016-2018  | 21.0%   | 29.8%   | 17.0%    | 1.4   | 135.2   |
| 2017-2019  | 15.0%   | 29.8%   | -2.0%    | 1.4   | 160.5   |
| 2018-2020  | 9.0%    | 29.8%   | -11.0%   | 1.1   | 219.6   |
| 2019-2021  | 33.0%   | 21.2%   | -10.0%   | 1.1   | 250.8   |
| 2020-2022  | -73.0%  | 59.8%   | -71.0%   | 1.2   | 130.8   |
| 2021-2023  | -42.0%  | 59.8%   | -43.0%   | 1.4   | 259.7   |
| 2022-2024  | -37.0%  | 52.3%   | -56.0%   | 1.4   | 329.9   |
| 2023-2025  | 10.0%   | 32.1%   | -52.0%   | 1.2   | 261.4   |

**Analysis:**

*   **CAGR:** The compounded annual growth rate has fluctuated significantly, indicating volatility in Salesforce's performance over different periods.
*   **MDD:** The Maximum Drawdown is relatively high in several periods, pointing to significant potential losses for investors.
*   **Alpha:** The consistently negative Alpha, especially in recent periods, signifies that Salesforce has underperformed its benchmark after accounting for risk.
*   **Beta:** The Beta hovers around 1.1 to 1.4, suggesting that CRM's price is more volatile than the market.
*   **Cap(B):** Market capitalization shows growth over time, except for the 2020-2022 period, indicating investor confidence (until recent drops).

**2) Recent Stock Price Fluctuations**

*   **Current Close:** 253.62
*   **Last Market Data:** Price: 262.9, Previous Close: 256.26, Change: 2.59
*   **5-day SMA:** 263.35
*   **20-day SMA:** 260.64
*   **60-day SMA:** 249.29

**Analysis:** The current price (253.62) is below all simple moving averages. The 5-day SMA is above the 20-day SMA, which is above the 60-day SMA. This suggests a short-term positive trend. The recent market data with a positive change indicates some rebound.

**3) RSI, PPO, Divergence, Expected Return**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment)
*   **RSI:** 37.53
*   **PPO:** -0.25
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (1 shares - Safe - MRI:0.80)
*   **Recent (20 days) relative divergence change:** -0.9 (Indicates short-term decline)
*   **Expected Return (%):** -749.7%

**Analysis:**

*   **MRI:** Suggests a medium level of investment risk.
*   **RSI:**  The RSI of 37.53 indicates that the stock is nearing oversold territory, potentially signaling a buying opportunity.
*   **PPO:** The negative PPO (-0.25) suggests a short-term downtrend.
*   **Hybrid Signal:** indicates buying opportunity.
*   **Divergence Change:**  The recent negative change in relative divergence confirms a short-term downward trend.
*   **Expected Return:** The very large negative expected return is a significant red flag, implying substantial potential losses if held long-term.

**4) Recent News & Significant Events:**

*   **Mixed Sentiment:** The news articles present a mixed picture. Some articles suggest Salesforce is ready to emerge as an AI winner, while others point to stock declines and concerns about jobs reports and earnings.
*   **Analyst Activity:** Some analysts love the stock and are raising price targets, indicating positive expectations from some quarters.
*   **Quiver Quantitative Data:** Indicates the stock is down, which could be attributed to negative sentiment.
*   **Finviz:** Lists Salesforce among cash-producing stocks to keep off the radar, suggesting skepticism.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy (Mean: 1.64)
*   **Target Price:** Average: 329.40, High: 475.00, Low: 223.00

**Analysis:** Despite the negative performance and some cautionary news, the overall analyst consensus remains positive, with a "Buy" rating and a significant average target price. However, the wide range between the high and low target prices indicates uncertainty among analysts.

**5) Recent Earnings Analysis:**

| Date       | EPS  | Revenue        |
|------------|------|----------------|
| 2025-12-04 | 2.2  | 10.26 B$       |
| 2025-09-04 | 1.97 | 10.24 B$       |
| 2025-05-29 | 1.61 | 9.83 B$        |
| 2024-12-04 | 1.6  | 9.44 B$        |
| 2025-12-04 | 1.6  | 9.44 B$        |

**Analysis:**

*   **EPS Growth:** EPS (Earnings Per Share) has generally increased over the periods, which is a positive sign.  The most recent EPS is a notable improvement.
*   **Revenue Growth:** Revenue has also shown consistent growth, indicating the company is expanding its sales.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-10-31   | $10.26B    | 78.02%        |
| 2025-07-31   | $10.24B    | 78.10%        |
| 2025-04-30   | $9.83B     | 76.96%        |
| 2025-01-31   | $9.99B     | 77.81%        |
| 2024-10-31   | $9.44B     | 77.71%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE       |
|--------------|------------|-----------|
| 2025-10-31   | $60.02B    | 3.48%     |
| 2025-07-31   | $61.33B    | 3.08%     |
| 2025-04-30   | $60.67B    | 2.54%     |
| 2025-01-31   | $61.17B    | 2.79%     |
| 2024-10-31   | $58.52B    | 2.61%     |

**Analysis:**

*   **Revenue:** Revenue has been consistently increasing over the past five quarters, indicating strong sales performance.
*   **Profit Margin:** The profit margins are very high (around 77-78%), showing excellent efficiency in managing costs relative to revenue.
*   **Equity:**  Equity has generally increased, reflecting growth in the company's net assets.
*   **ROE:** Return on Equity (ROE) fluctuates, but generally shows that Salesforce is generating profit from shareholder equity. The most recent ROE of 3.48% is the highest in the provided data.

**7) Comprehensive Analysis (Summary)**

Salesforce (CRM) presents a mixed picture.

*   **Underperformance:** It has significantly underperformed the S&P 500, and exhibits negative Alpha over multiple periods.
*   **Recent Improvement:** There are recent improvements in revenue, EPS, and ROE. Recent price movement indicate sharp rebound.
*   **Analyst Optimism vs. Market Reality:** Analysts are generally positive, with a "Buy" consensus and high target prices, but the stock price has struggled, and news sentiment is mixed.
*   **Mixed Signals:** The MRI suggests a medium level of investment risk, while the very negative expected return raises concerns.
*   **Technical Indicators:** The RSI nearing oversold territory and the negative PPO provide conflicting signals.

**Overall Conclusion:**

CRM currently appears to be a high-risk, high-reward investment. While financial performance is improving and analysts remain optimistic, the historical underperformance, negative expected return, and mixed news sentiment should give investors pause. Careful consideration of risk tolerance and further due diligence is warranted before investing in CRM. Focus on the upcoming reports for a more definite investment conclusion.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.